Methadone disposition in patients with chronic liver disease
β Scribed by Novick, David M; Kreek, Mary Jeanne; Fanizza, Angela M; Yancovitz, Stanley R; Gelb, Alvin M; Stenger, Richard J
- Book ID
- 109843078
- Publisher
- Nature Publishing Group
- Year
- 1981
- Tongue
- English
- Weight
- 596 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0009-9236
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In the present study the effect of metastatic liver disease on hepatic drug metabolism has been examined by studying the pharmacokinetics of antipyrine and the urinary excretion of antipyrine and its three major metabolites (4-hydroxyantipyrine, norantipyrine, and 3-hydroxymethylantipyrine) in 12 pa
with consequent organ dysfunction. Carnitine metabolism Carnitine metabolism was studied in 79 patients with could be disturbed by a variety of mechanisms in patients chronic liver disease, including 22 patients with noncirwith chronic liver disease. Dietary intake of carnitine could rhotic liver di